glp-1 lawsuits news Ozempic Lawsuit: July 2026 Blindness and Gastroparesis Claims Fmr. FDA Commissioner weighs in

PMOS and Sexual Dysfunction Women with Polycystic Metabolic-Ovarian Syndrome (PMOS) frequently experience sexual dysfunction driven by multiple vectors: androgen disruption, insulin resistance, body image distress, and altered dopamine signalling

acnes), previously known as Propionibacterium acnes (P

Enhances energy, supports skin health, and helps maintain a youthful glow

The new label for Ozempic is based on the results of the FLOW trial, which showed a statistically significant reduction in kidney disease progression, as well as cardiovascular and kidney death with a 1 mg/kg weekly dose of the injectable drug compared to placebo

Retrieved December 1, 2016

Reactive oxygen species are unstable molecules produced during normal metabolism, but in excess, they wreak havoc